Ars Pharmaceuticals Inc (SPRY) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Ars Pharmaceuticals Inc   (NASDAQ: SPRY)

Ars Pharmaceuticals Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SPRY Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 70.91 % 65.43 % 47.43 %
Gross Margin (Q2 TTM) 71.21 % 71.73 % 66.39 % 46.67 %
Gross Profit Margin 5 Yr. Avg. - 67.82 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) 3.02 % 22.25 % 19.59 % 21.4 %
EBITDA Margin (Q2 TTM) -129.1 % 25.28 % 20.86 % 19.31 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.56 % 22.45 %
Operating Margin (Q2 MRQ) -182.62 % 17.27 % 16.57 % 16.73 %
Operating Margin (Q2 TTM) -184.96 % 20.33 % 17.92 % 16.52 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.66 % 10.93 % 14.14 %
Pre-Tax Profit Margin (Q2 TTM) -131 % 16.7 % 12.86 % 13.13 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.99 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) -185.21 % 10.09 % 8.14 % 11.6 %
Net Margin (Q2 TTM) -184.24 % 13.13 % 9.99 % 10.8 %
Net Margin 5 Yr. Avg. - 5.8 % 6.08 % 9.9 %



Business Segment Profit Margin
 
Revenue under supply agreements
  Explore Revenue under supply agreements Segment  -
Denmark
  Explore Denmark Segment  -
Product
  Explore Product Segment  -
US
  Explore US Segment  -
DK
  Explore DK Segment  -
Non Us
  Explore Non Us Segment  -